Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease
Ze Chen, Ruifeng Tian, Zhi‐Gang She, et al.
Free Radical Biology and Medicine (2020) Vol. 152, pp. 116-141
Open Access | Times Cited: 899

Showing 1-25 of 899 citing articles:

Macrophages in immunoregulation and therapeutics
Shanze Chen, Abdullah F. U. H. Saeed, Quan Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 679
Immune cell-mediated features of non-alcoholic steatohepatitis
Thierry Huby, Emmanuel L. Gautier
Nature reviews. Immunology (2021) Vol. 22, Iss. 7, pp. 429-443
Open Access | Times Cited: 370
Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
Patricia Rada, Águeda González‐Rodríguez, Carmelo García‐Monzón, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 9
Open Access | Times Cited: 362
NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications
Huai‐Qiang Ju, Jin‐Fei Lin, Tian Tian, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 356
Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy
Johanna C. Arroyave-Ospina, Zongmei Wu, Yana Geng, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 174-174
Open Access | Times Cited: 344
Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver
Erika Ramos‐Tovar, Pablo Muriel
Antioxidants (2020) Vol. 9, Iss. 12, pp. 1279-1279
Open Access | Times Cited: 211
Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review
Anna Pia Delli Bovi, F. Marcianò, Claudia Mandato, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 203
Different effects of nano- and microplastics on oxidative status and gut microbiota in the marine medaka Oryzias melastigma
Hye-Min Kang, Eunjin Byeon, Haksoo Jeong, et al.
Journal of Hazardous Materials (2020) Vol. 405, pp. 124207-124207
Closed Access | Times Cited: 195
Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)
Xiaohan Xu, Kyle L. Poulsen, Lijuan Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 191
Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy
Yu Gao, Wei Zhang, Liqin Zeng, et al.
Redox Biology (2020) Vol. 36, pp. 101635-101635
Open Access | Times Cited: 181
Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment
Xiangyu Guo, Xunzhe Yin, Zuojia Liu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15489-15489
Open Access | Times Cited: 171
Novel target for treating Alzheimer’s Diseases: Crosstalk between the Nrf2 pathway and autophagy
Wei Zhang, Feng Cong, Hong Jiang
Ageing Research Reviews (2020) Vol. 65, pp. 101207-101207
Closed Access | Times Cited: 148
New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress
Domenico Ferro, Francesco Baratta, Daniele Pastori, et al.
Nutrients (2020) Vol. 12, Iss. 9, pp. 2762-2762
Open Access | Times Cited: 140
Peroxisomal β-oxidation acts as a sensor for intracellular fatty acids and regulates lipolysis
Lianggong Ding, Wenfei Sun, Miroslav Baláž, et al.
Nature Metabolism (2021) Vol. 3, Iss. 12, pp. 1648-1661
Open Access | Times Cited: 127
Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments
Samar A. Antar, Nada A. Ashour, Marwa Sharaky, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115734-115734
Open Access | Times Cited: 127
PPAR-γ signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets
Hao Chen, Huabing Tan, Juan Wan, et al.
Pharmacology & Therapeutics (2023) Vol. 245, pp. 108391-108391
Closed Access | Times Cited: 103
Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
Xiaodong Zhou, Jingjing Cai, Giovanni Targher, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 96
Drug-induced oxidative stress in cancer treatments: Angel or devil?
Hao Jiang, Jing Zuo, Bowen Li, et al.
Redox Biology (2023) Vol. 63, pp. 102754-102754
Open Access | Times Cited: 96
NOX Dependent ROS Generation and Cell Metabolism
Tiziana Pecchillo Cimmino, Rosario Ammendola, Fabio Cattaneo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2086-2086
Open Access | Times Cited: 78
Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease
Tobias Puengel, Hanyang Liu, Adrien Guillot, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2668-2668
Open Access | Times Cited: 73
Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLD
Kathleen Clare, John Dillon, Paul Brennan
Journal of Clinical and Translational Hepatology (2022) Vol. 10, Iss. 5, pp. 939-946
Open Access | Times Cited: 70
Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation
Neda Yahoo, Michael Dudek, Percy A. Knolle, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 538-551
Open Access | Times Cited: 61
Reactive oxygen species-sensitive materials: A promising strategy for regulating inflammation and favoring tissue regeneration
Jing Zhou, Chao Fang, Chao Rong, et al.
Smart Materials in Medicine (2023) Vol. 4, pp. 427-446
Open Access | Times Cited: 43
Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction
Karli R. LeFort, Wiramon Rungratanawanich, Byoung‐Joon Song
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 31
ONOO–-activatable and LD-traced NIR fluorescent probe for mechanism study and early diagnosis of NAFLD and diabetes induced liver injury
Nannan Wang, Xiaoyan Lu, Jiamin Wang, et al.
Sensors and Actuators B Chemical (2024) Vol. 412, pp. 135806-135806
Closed Access | Times Cited: 30
Page 1 - Next Page

Scroll to top